
Results
15
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
15 companies
Laurus Labs
Market Cap: ₹987.9b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,830.00
7D
2.7%
1Y
118.3%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$50.9b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$55.55
7D
15.3%
1Y
126.0%
Anthem Biosciences
Market Cap: ₹465.0b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹825.65
7D
5.3%
1Y
10.1%
Emcure Pharmaceuticals
Market Cap: ₹367.2b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,936.70
7D
1.4%
1Y
38.3%
Neuland Laboratories
Market Cap: ₹275.8b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹21,499.95
7D
11.9%
1Y
67.5%
Acutaas Chemicals
Market Cap: ₹266.9b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,260.60
7D
0.8%
1Y
151.8%
Rubicon Research
Market Cap: ₹253.8b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,533.40
7D
2.2%
1Y
n/a
Aether Industries
Market Cap: ₹210.3b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹1,584.40
7D
6.3%
1Y
111.7%
Granules India
Market Cap: ₹207.7b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹838.20
7D
0.5%
1Y
86.5%
Jinyu Bio-technology
Market Cap: CN¥14.3b
Engages in the research and development, production, and sale of veterinary biological products in China and internationally.
600201
CN¥13.09
7D
11.7%
1Y
51.3%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.4b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥43.07
7D
-0.9%
1Y
-12.1%
Shilpa Medicare
Market Cap: ₹144.7b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.
530549
₹740.05
7D
22.6%
1Y
80.5%
Viyash Scientific
Market Cap: ₹119.1b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹272.90
7D
8.3%
1Y
55.9%
Strides Pharma Science
Market Cap: ₹91.9b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹997.20
7D
-7.0%
1Y
24.9%
Sakar Healthcare
Market Cap: ₹20.5b
Research, develops, manufactures, and sells pharmaceutical products in India.
SAKAR
₹919.70
7D
8.9%
1Y
172.9%